ArriVent BioPharma, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -49,893 | -43,320 | -35,544 | -34,978 |
EBIT | -52,691 | -46,111 | -38,823 | -38,316 |
Net Income | -49,893 | -43,320 | -35,544 | -34,978 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -39,581 | -41,892 | -30,658 | -35,798 |
Cash | 154,682 | 62,103 | 45,540 | 112,672 |
Basic Shares | 47,606 | 45,067 | 38,462 | 41,912 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -166,308 | -80,488 | -69,333 | -36,906 |
EBIT | -177,534 | -94,308 | -74,590 | -73,812 |
Net Income | -166,308 | -80,488 | -69,333 | -36,906 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -160,588 | -70,212 | -55,842 | -43,631 |
Cash | 45,540 | 74,293 | 150,389 | 163,372 |
Basic Shares | 38,462 | 31,469 | 31,956 | 33,493 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.05 |
2026-03-31 | -$0.96 |
2025-12-31 | -$0.78 |
2025-09-30 | -$0.83 |